LAMA3 and cholangiocarcinoma: Nevertheless, we observed LAMA3 presence in 37 cases (74%) of CCA tissues, with its levels showing no significant correlation with either survival time or the clinicopathological aspects of the disease (Supplementary Fig. S2).